The second phase trial on average showed that patients administered with the drug recovered 2.5 days earlier than other patients. (Representative image) An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The drug, which was … Read more
Covid-19 update: However, Dr. Reddy’s will continue a late-stage North American trial of Avigan in patients with mild to moderate Covid-19 symptoms. (Reuters image) Covid- 19 update: Indian pharmaceutical giant Dr. Reddy’s Laboratories on Wednesday said that it had terminated its clinical study of Fujifilm Holdings’ COVID-19 drug Avigan in patients with moderate to severe … Read more
The companies said the vaccine was well tolerated with mild to moderate fever in fewer than 20% of the participants. (Representational image: Reuters) Pfizer Inc. and BioNTech SE said the Covid-19 vaccine they are jointly developing is on track to be submitted for regulatory review as early as October, as they released additional data from … Read more